{"organizations": ["Novartis", "Reuters", "Amgen"], "uuid": "67bedbfc4afa571706e358e4633a18a00e47ad7d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.newsdump.com", "main_image": "", "site_section": "http://www.newsdump.com/feed/", "section_title": "NewsDump.com, US News, Headlines, Latest USA News, US Sports, US Politics, Football, Business, Celebs, Baseball, Hockey, Basketball", "url": "http://www.newsdump.com/article/novartis-biosimilar-copycat-takes-aim-at-amgens-drug-enbrel", "country": "CZ", "title": "Novartis biosimilar copycat takes aim at Amgen's drug Enbrel", "performance_score": 0, "site": "newsdump.com", "participants_count": 0, "title_full": "Novartis biosimilar copycat takes aim at Amgen's drug Enbrel", "spam_score": 0.0, "site_type": "news", "published": "2015-10-02T10:33:00.000+03:00", "replies_count": 0, "uuid": "67bedbfc4afa571706e358e4633a18a00e47ad7d"}, "author": "", "url": "http://www.newsdump.com/article/novartis-biosimilar-copycat-takes-aim-at-amgens-drug-enbrel", "ord_in_thread": 0, "title": "Novartis biosimilar copycat takes aim at Amgen's drug Enbrel", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Published By: Reuters - Business - Today \nZURICH (Reuters) - The U.S. Food and Drug Administration has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimi...", "external_links": [], "published": "2015-10-02T10:33:00.000+03:00", "crawled": "2015-10-02T13:13:39.735+03:00", "highlightTitle": ""}